- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Leveraged Finance
- Mergers and Acquisitions
- Middle East and Islamic Finance and Investment
- Private Credit & Special Situations Investing
- Private Equity
- Real Estate
- Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Insurance Coverage and Recovery
- Intellectual Property, Patent, Trademark and Copyright Litigation
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy
- Financial Services
- Food and Beverage
- Franchise and Hospitality
- Higher Education
- Life Sciences and Healthcare
- Technology
- #MeToo
- COVID-19 Vaccine Rollout
- Coronavirus
- Crisis Practice
- Focus on Women's Health
- The New Administration: Enforcement and Legislative Impact
- Careers
- News & Insights
- About
- Languages
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Leveraged Finance
- Mergers and Acquisitions
- Middle East and Islamic Finance and Investment
- Private Credit & Special Situations Investing
- Private Equity
- Real Estate
- Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Insurance Coverage and Recovery
- Intellectual Property, Patent, Trademark and Copyright Litigation
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy
- Financial Services
- Food and Beverage
- Franchise and Hospitality
- Higher Education
- Life Sciences and Healthcare
- Technology
- #MeToo
- COVID-19 Vaccine Rollout
- Coronavirus
- Crisis Practice
- Focus on Women's Health
- The New Administration: Enforcement and Legislative Impact
取扱業務
日本語版をご希望の場合はこちらをご覧ください。
ウェブページを見る日本語 - Japanese
オフィス（国内外拠点）
ニュース＆インサイト
キング＆スポールディング、アジア開発銀行（ADB）官民連携部の前部長を採用
Tokyo Dispute Resolution & Crisis Management Newsletter – November 2018
東京オフィス設立4周年および 紛争解決・危機管理ニュースレター（通算35版リリース）について － 2019年9月号
東京オフィス 紛争解決・危機管理ニュースレター — 2020 年 5 月
東京オフィス 紛争解決・危機管理ニュースレター — 2020 年 6月
東京オフィス 紛争解決・危機管理ニュースレター — 2020 年 7月
東京オフィス 紛争解決・危機管理ニュースレター — 2020 年 8月
東京オフィス 紛争解決・危機管理ニュースレター — 2020 年 10月
Related Lawyers
閉じる
Recognition
Ranked Band 5 in New York Bankruptcy/Restructuring
Chamber USA 2020
Ranked Band 1 in Georgia Bankruptcy/Restructuring
Chamber USA 2020
One individual notes that the team is "very well-connected, talented and versatile."
Chambers USA 2020
Clients view them as "the top restructuring firm in the Atlanta market."
Chambers USA 2020
One interviewee reports: "King & Spalding is a well-respected law firm with a deep bench of creditor clients."
Chambers USA 2020
"There's a lot of creativity there," comments another, continuing: "They offer a personal service."
Chambers USA 2020
Named a leading Tier 1 Bankruptcy practice.
Chambers USA 2019
Band 1 – Georgia – Bankruptcy/Restructuring
CHAMBERS USA 2019
Five bankruptcy lawyers are recognized as leading individuals.
CHAMBERS USA 2019
Three of our bankruptcy lawyers are Fellows of the American College of Bankruptcy
THE AMERICAN COLLEGE OF BANKRUPTCY
One of the most active bankruptcy law firms based on representations in active cases.
The Deal
"They are top-notch. They are responsive, bring substantial resources, and analyze the issues thoroughly and quickly."
CHAMBERS USA 2019
"They do an excellent job, they are very practical and pragmatic."
CHAMBERS USA 2019
Clients praise the "breadth and expertise" the firm offers.
CHAMBERS USA 2019
Finalist for Team of the Year: Restructuring and Insolvency and Deal of the Year: Restructuring and Insolvency (Nine West Restructuring)
IFLR1000 US 2020 Awards